Institutionelle bei Immunex

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Wellington Management Company 25,394,162 $641,456,532
Barclays Bank Plc 15,063,318 $380,499,412
Vanguard Group, Inc. (The) 9,837,819 $248,503,307
Taunus Corporation 7,344,309 $185,517,245
Orbimed Advisors Inc. 6,344,800 $160,269,648
FMR Corporation (Fidelity Management & Research Corp) 5,934,850 $149,914,311
Alger (Fred) Management Inc 5,483,810 $138,521,040
Zurich Scudder Investments, Inc. 4,350,090 $109,883,273
Brinson Partners, Inc. 4,117,850 $104,016,891
Dresdner Bank Ag 4,016,190 $101,448,959

Topliste der investierten Fonds
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 14,636,734 $369,723,900
Vanguard Specialized-Health Care Fund 13,530,600 $341,782,956
Fidelity Growth Company Fund 7,609,800 $192,223,548
Fidelity Aggressive Growth Fund 7,298,700 $184,365,162
Fidelity Independence Fund 7,182,500 $181,429,950
Vanguard Index 500 Fund 4,502,981 $113,745,300
Merrill Lynch Fundamental Growth Fund 3,665,000 $92,577,900
Fidelity Select Portfolios - Biotechnology 3,647,740 $92,141,912
Eaton Vance Global Health Portfolio 3,200,000 $80,832,000
American Century Growth Fund 3,087,000 $77,977,620